Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.59
Delayed Data
As of Mar 31
 -0.07 / -4.22%
Today’s Change
0.97
Today|||52-Week Range
2.02
-15.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues751.8K1.1M2.3M1.5M
 
 
 
 
 
Cost of Goods Sold82.0K146.4K682.5K314.5K
 
 
 
 
 
Depreciation And Amortization111.3K124.1K125.3K--
 
 
 
 
 
Operating ExpensesGross Income558.6K804.2K1.4M1.1M
 
 
 
 
 
General Expenses9.1M8.6M6.7M6.4M
 
 
 
 
 
Research And Development5.2M5.1M4.2M2.3M
 
 
 
 
 
Total Operating Expenses9.3M8.9M7.5M6.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.6M-7.8M-5.3M-5.2M
 
 
 
 
 
Extraordinary Credit392.5K0.000.000.00
 
 
Extraordinary Charge-2.6M-1.5M-472.7K-1.2M
 
 
 
 
 
Pre-Tax Equity Earnings0.00---262.2K-261.6K
 
 
 
Interest Expense On Debt943.8K914.1K920.9K927.4K
 
 
 
 
 
Other Expenses-6.8K-5.3K53.5K771.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.7M-10.2M-6.9M-6.9M
 
 
 
 
 
Net Income-11.7M-10.2M-6.9M-6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS144.8M150.0M150.2M149.9M
 
 
 
 
 
Shares To Calculate EPS Diluted144.8M150.0M150.2M149.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.07-$0.05-$0.05
 
 
 
 
 
EPS Diluted-$0.08-$0.07-$0.05-$0.05
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account